電子皮膚パッチ 2023-2033年: IDTechEx

電子皮膚パッチ市場が2033年までに年間270億米ドルを超える規模に

電子皮膚パッチ 2023-2033年

実績データ、10年間市場予測、インタビューに基づく有力企業概要と技術分析を含む用途別13種のフレキシブル、ウェアラブルの電子皮膚パッチ商用化に関するこれまでにない包括的な分析。


製品情報 概要 目次 価格 Related Content
このレポートは電子皮膚パッチ市場、技術、有力企業を分析しています。13用途分野をカバーし、2010-2022年の市場実績データと2023年から2033年の市場予測を網羅し、製品分野に関する包括的な調査となっています。IDTechExは、電子皮膚パッチ市場は2033年までに270億米ドルを超える規模に成長するとみており、莫大なビジネスチャンスがあることを明らかにしています。
「電子皮膚パッチ 2023-2033年」が対象とする主なコンテンツ
(詳細は目次のページでご確認ください)
● 全体概要と結論
● 電子皮膚パッチのイントロダクション
● 糖尿病(持続血糖測定とインスリンポンプ)
●  心拍モニタリング(ホルター心電図、心血管イベント・モニター、連続装用ホルター心電計、携行型心臓テレメトリー)
● 一般的患者モニタリング(入院患者モニタリング、外来患者モニタリング、分散型臨床試験)
●  体温センシング
● 電気刺激
● イオントフォレシス
● 発汗センシング
● その他の用途:
□ 体動センシング、創傷センシングなど
● 製造プロセス技術と材料
● 2010-2022年実績データを含む電子皮膚パッチ市場総合分析
●  電子皮膚パッチ予測2023-2033年
 
「電子皮膚パッチ 2023-2033年」は以下の情報を提供します
電子皮膚パッチ製品と背後にある技術レビュー:
  • 製品分野とその細目分野の沿革と背景
  • 各分野の重要技術概要
  • 製品分野のトレンドとテーマの全体概要
  • 複数有力企業のベンチマーク比較と分析
主要電子皮膚パッチ製品の包括的な市場分析:
  • 糖尿病管理の状況(歴史的背景、CGMの台頭、インスリンポンプとパッチ型ポンプ、自動制御システム開発と非侵襲性グルコース監視への開発)
  • 心血管系皮膚パッチのエコシステム分析(有力製品の状況、同分野の差別化(例、ホルター、イベント、連続装用ホルターとMCT)と資金回収と資金調達のシナリオ)
  • バイタルサイン・モニタリング(業界有力企業の技術とビジネスモデル分析、臨床試験における利用拡大)
  • 他のニッチ分野分析(各種モニタリング使用事例、イオントフォレシス、電気刺激など)
市場全体分析:
  • 電子皮膚パッチ有力企業評価(各主要セクターの130社以上対象)
  • 電子皮膚パッチ市場の2010-2022年実績データ(11セクター対象)
  • 13セクター対象の2023-2033年市場予測(それぞれ完全な説明、制約事項と算定方式を含む)
 
This report characterizes the markets, technologies, and players in electronic skin patches. With coverage across 13 application areas, historic electronic skin patch market data from 2010-2022 and electronic skin patch market forecasts from 2023 to 2033, it is the most comprehensive study compiled for this product area. It reveals significant opportunity, with the electronic skin patch market forecast to grow to over US$27B by 2033.
 
Electronic skin patches are wearable products attached to the skin. The electronic element involves the integration of electronic functionality such as sensors, actuators, processors, and communication, allowing products to become connected and "smart". In many ways, electronic skin patches act as the ultimate wearable electronic devices, augmenting the wearer with minimal encumbrance and maximum comfort. As such, interest in electronic skin patches soared as a by-product of the significant hype and market growth around "wearables" starting in 2014.
 
However, several product types within the sector transcend this hype. Electronic skin patch product areas in diabetes management and cardiac rhythm monitoring have superseded incumbent options in established markets to create billions of dollars of new revenue each year for the companies at the forefront of this wave. However, success is not ubiquitous; each market discussed within this report sits within a unique ecosystem, with different players, drivers, limitations, and history to build on.
 
As such, the report looks at each of the application areas for electronic skin patches in turn, discussing the relevant technology, product types, competitive landscape, industry players, pricing, historic revenue, and electronic skin patch market forecasts. The areas covered include diabetes management (CGM and insulin pumps), cardiovascular monitoring devices (MCT, Holter monitors, and event monitors), general patient monitoring (both inpatient and outpatient), temperature sensing, drug and cosmetic delivery patches, electrical stimulation devices, sweat sensing, and other emerging options such as wound care, motion sensing, and more. The report also discusses manufacturing of electronic skin patches, including focus on emerging material options as well as the technology underlying the manufacturing process. The report contains historic revenue data for each of the product sectors studied back to 2010, including data by company for the larger sectors. The report also contains detailed market forecasting over 10 years for each of the key application areas.
 
Source: Electronic Skin Patches 2023-2033
 
The research behind the report has been compiled over several years by IDTechEx analysts. It follows existing coverage of areas such as wearable technology, flexible electronics, stretchable and conformal electronics, electronic textiles, advanced wound care, bioelectronics, cardiovascular diseases, diabetes, sensors, and other medical devices. The methodology involved a mixture of primary and secondary research, with a key focus on speaking to executives and scientists from companies developing commercial electronic skin patches. As such, the report analyses over 130 companies and projects, both current and historic, including over 40 profiles and case studies.
 
Unique position and experience behind the report
IDTechEx is afforded a particularly unique position in covering this topic. The analyst team builds on decades of experience covering emerging technology markets, and particularly areas, such as flexible electronics, which are central to electronic skin patches. This has been historically supported by IDTechEx's parallel activities in organising the leading industry conferences and exhibitions covering flexible and wearable electronics, as well as smaller events covering specific innovation trends such as for healthcare sensors or related areas. IDTechEx has the unique ability to curate a network in these topic areas, facilitating the analysis in this report.
This report provides critical market intelligence about the product sector and each of the 13 electronic skin patch application sectors involved. This includes:
 
A review of the context and technology behind electronic skin patch products:
  • History and context for the product area and each subsector
  • General overview of important technologies within each sector
  • Overall look at electronic skin patches trends and themes within the product area
  • Benchmarking and analysis of different players throughout
 
Full market characterization for each major electronic skin patch product:
  • Review of the diabetes management landscape, including historical context, the rise of CGM, development of insulin pumps and patch pumps, closed loop systems and development towards non-invasive glucose monitoring
  • Review of the ecosystem for cardiovascular skin patches, including their context within competitive products, the differentiation within the sector (e.g. Holter, Event, Extended Holter, and MCT), and the reimbursement and funding scenario.
  • Vital sign monitoring more generally, including technology and business model reviews across players in the industry and the growing use in clinical trials
  • Reviews of other niche sectors, including various temperature monitoring use cases, iontophoresis, electrical stimulation and more
 
Market analysis throughout:
  • Reviews of electronic skin patch players throughout each key sector, analyzed from over 130 companies
  • Historic electronic skin patch market data from 2010-2022 for 11 sectors
  • Market forecasts from 2023-2033 for 13 sectors, including full narrative, limitations, and methodologies for each
IDTechEx のアナリストへのアクセス
すべてのレポート購入者には、専門のアナリストによる最大30分の電話相談が含まれています。 レポートで得られた重要な知見をお客様のビジネス課題に結びつけるお手伝いをいたします。このサービスは、レポート購入後3ヶ月以内にご利用いただく必要があります。
詳細
この調査レポートに関してのご質問は、下記担当までご連絡ください。

アイディーテックエックス株式会社 (IDTechEx日本法人)
担当: 村越美和子 m.murakoshi@idtechex.com
Table of Contents
1.EXECUTIVE SUMMARY
1.1.Scope of the report
1.2.Benefits of electronic skin patches as a form factor
1.3.Market push and pull drivers
1.4.Skin patch applications overview
1.5.Diabetes management devices: electronic skin patches increase patient comfort
1.6.Diabetes management device roadmap: Glucose sensors
1.7.Key points for diabetes management devices: continuous glucose monitoring
1.8.Diabetes management device roadmap: Insulin delivery
1.9.Key points for diabetes management devices: insulin delivery
1.10.Atrial fibrillation: electronic skin patches addresses key industry pain points
1.11.Diagnosis process for atrial fibrillation and other arrhythmias
1.12.Key points for cardiac monitoring: Holter, mobile cardiac telemetry & event monitor
1.13.Vital sign monitoring: electronic skin patches increase patient mobility
1.14.Emerging application: Decentralized clinical trials
1.15.Key points for general vital sign monitoring
1.16.Other applications: temperature, electrical stimulation, iontophoresis and sweat sensing
1.17.Electronic skin patch manufacturing process
1.18.Material requirements for an electronic skin patch
1.19.Electronic skin patches global market annual revenue historic data and forecast 2010-2033
1.20.Electronic skin patches global market annual revenue forecast 2022-2033
2.INTRODUCTION
2.1.How to use this report
2.2.Definitions
2.3.The case for skin patches: augmenting the human body
2.4.Electronic skin patches within wearable technology progress
2.5.Benefits of electronic skin patches as a form factor
2.6.Market push and pull drivers
2.7.Key milestones in the history of skin patches
2.8.COVID-19 effect on electronic skin patches
2.9.Privacy and IT challenges
2.10.Reimbursement drives commercial business models
2.11.Reimbursement codes (US)
2.12.Skin patch applications overview
2.13.Skin patch applications overview
2.14.Skin patch applications overview
3.DIABETES MANAGEMENT VIA SKIN PATCHES
3.1.1.Background: Introduction to diabetes
3.1.2.The prevalence of diabetes
3.1.3.Diabetes management ecosystem
3.1.4.Background: Diabetes on the rise
3.1.5.Diabetes management device roadmap: Summary
3.1.6.Electronic skin patches in diabetes management: company profiles
3.2.Continuous glucose monitoring
3.2.1.Diabetes management device roadmap: Glucose sensors
3.2.2.Continuous glucose monitors (CGMs) take the form of skin patches
3.2.3.CGMs are superseding test strips
3.2.4.CGM reimbursement for type 2 is currently limited
3.2.5.CGM usage in hospitals
3.2.6.Anatomy of a typical CGM device
3.2.7.CGM: Technology
3.2.8.CGM sensor manufacturing and anatomy
3.2.9.Comparison metrics for CGM devices
3.2.10.Example: Accuracy of CGM devices over time
3.2.11.CGM: Overview of key players
3.2.12.Abbott Laboratories: CGM business
3.2.13.Dexcom: Introduction
3.2.14.Medtronic: Introduction
3.2.15.Ascensia, POCTech and Yuwell
3.2.16.Senseonics
3.2.17.Non-invasive glucose monitoring
3.2.18.Conclusions for continuous glucose monitors
3.2.19.Insulin pumps
3.2.20.Insulin delivery: Introduction
3.2.21.Diabetes management device roadmap: Insulin delivery
3.3.Insulin Pumps
3.3.1.Insulin patch pumps
3.3.2.Insulin pump market
3.3.3.Insulin pump players and market share
3.3.4.Key trends for the industry
3.3.5.Accu-Chek Solo by Roche
3.3.6.What do patch pumps offer over infusion pumps?
3.3.7.Insulin pump technology roadmap
3.4.Linking insulin pumps and CGM: Towards closed loop and the artificial pancreas
3.4.1.Today: Hybrid closed loop systems
3.4.2.The objective: Closing the feedback loop
3.4.3.Medtronic leads development of hybrid closed-loop
3.4.4.Insulet: Omnipod 5
3.4.5.Tidepool: Tidepool Loop
3.4.6.Outlook for insulin pumps
3.4.7.Conclusions for insulin delivery
4.CARDIAC RHYTHM MONITORING SKIN PATCHES
4.1.1.Cardiovascular disease (CVD)
4.1.2.Atrial fibrillation and early detection
4.1.3.Biopotential indicator and the electrocardiogram
4.1.4.Diagnosis process for atrial fibrillation and other arrhythmias
4.1.5.ECG monitor pain points that skin patches solve
4.1.6.Cardiac monitoring skin patches: device types
4.1.7.Cardiac monitoring device types - skin patches
4.1.8.Cardiac rhythm monitoring skin patches: companies and product types
4.1.9.Cardiac monitoring players and devices (1)
4.1.10.Cardiac monitoring players and devices (2)
4.1.11.How many ECG channels does a skin patch need?
4.1.12.ECGs use wet electrodes and strong adhesives
4.1.13.Dry electrodes may improve longer wear experience
4.1.14.ECG skin patches are packaged with support AI
4.1.15.Reimbursement codes for wearable cardiac monitors
4.1.16.Wearable vs implantable monitoring
4.1.17.Phillips (Biotelemetry)
4.1.18.iRhythm
4.1.19.Boston Scientific (Preventice Solutions)
4.1.20.Conclusions for cardiac monitoring skin patches
4.1.21.Cardiac rhythm monitoring skin patches: company profiles
4.2.Fetal heart rate monitoring
4.2.1.Fetal monitoring
4.2.2.GE Healthcare (Monica Healthcare)
4.2.3.Conclusions for fetal heart rate monitoring
5.GENERAL PATIENT MONITORING SKIN PATCHES
5.1.General vital sign monitoring
5.2.Drivers and requirements for skin patches
5.3.Application potential for general purpose devices
5.4.Deployment challenges for general monitoring devices
5.5.Evolving market dynamics over time
5.6.Decentralized clinical trials
5.7.General patient monitoring skin patch players
5.8.Inpatient monitoring
5.9.Going wireless
5.10.Shifting to outpatient monitoring
5.11.Post-Discharge Monitoring: Reducing Readmissions
5.12.Neutropenia, post-chemotherapy vital monitoring
5.13.Drawback of remote patient monitoring
5.14.BioIntelliSense
5.15.Vivalink
5.16.VitalConnect
5.17.Conclusions for general patient monitoring skin patches
6.TEMPERATURE SENSING SKIN PATCHES
6.1.Body temperature
6.2.Skin patches for temperature sensing
6.3.Temperature sensor options
6.4.Fever and COVID-19
6.5.Fertility monitoring
6.6.Temperature monitor skin patch companies
6.7.Blue Spark
6.8.Conclusions for temperature monitoring skin patches
7.ELECTRICAL STIMULATION WITH SKIN PATCHES
7.1.Introduction
7.2.Differentiation of electrical stimulation
7.3.NMES, EMS, and FES
7.4.Application of NMES/EMS
7.5.Electrical stimulation parameters
7.6.First Kind Medical: gecko
7.7.TENS
7.8.Percutaneous Electrical Stimulation
7.9.Communication with Bioelectronic Implants
7.10.Electrical stimulation skin patches: company profiles
7.11.Conclusions for electrical stimulation skin patches
8.IONTOPHORESIS SKIN PATCHES
8.1.Introduction
8.2.Iontophoresis for Drug Delivery
8.3.Commercial Activity: Iontophoresis for Drug Delivery
8.4.Iontophoresis for Drug Delivery: Companies
8.5.Reverse Iontophoresis
8.6.Nemaura Medical
8.7.Conclusions for iontophoresis and reverse iontophoresis skin patches
9.SWEAT SENSING SKIN PATCHES
9.1.Introduction
9.2.Galvanic Skin Response
9.3.Chemical Sensing in Sweat
9.4.Analytes in Sweat
9.5.Sweat Sensing: Companies
9.6.Conclusion for sweat sensing
10.OTHER ELECTRONIC SKIN PATCH APPLICATIONS
10.1.Wound Monitoring
10.2.Wound Monitoring: Examples
10.3.Wound Treatment: Potential Directions
10.4.Motion
10.5.Motion: Skin Patches vs Other Form Factors
10.6.Motion: Inertial Measurement Units and Concussion Monitoring
10.7.Motion: Displacement Sensors
10.8.Communication with Implants
10.9.Communication with Implants: Proteus Digital Health
10.10.Ultrasound: Bladder Volume Sensing
10.11.Respiration Sound
11.MANUFACTURING ELECTRONIC SKIN PATCHES
11.1.1.Electronic skin patch manufacturing value chain
11.2.Manufacturing methods
11.2.1.Electronic skin patch manufacturing process
11.2.2.Higher volumes will encourage transition to R2R manufacturing
11.2.3.Offering S2S and R2R production enables different order sizes
11.2.4.Increased demand for wearable/medical manufacturing leads to expansion plans
11.2.5.Membrane switch manufacturers with screen printing capabilities transition to electronic skin patches
11.2.6.Interest in wearable sensing continues to grow but technical challenges remain
11.2.7.Development from conventional boxed to flexible hybrid electronics will be challenging
11.2.8.GE Research: Manufacturing of disposable wearable vital signs monitoring devices
11.2.9.NextFlex: Utilizing electronics in silicone to make more comfortable skin patches
11.2.10.Key points: Electronic skin patch manufacturing
11.3.Materials
11.3.1.'Full-stack' material portfolios reduce adoption barriers
11.3.2.Material requirements for an electronic skin patch
11.3.3.Progress in using liquid metal alloys as stretchable inks for wearable electronics
11.3.4.New printed electrode materials from Henkel
11.3.5.Key points: Materials for electronic skin patches
12.MARKET FORECASTS
12.1.1.Electronic skin patches global market annual revenue historic data 2010-2022
12.1.2.Electronic skin patches global market annual revenue historic data and forecast 2010-2033
12.1.3.Electronic skin patches global market annual revenue historic data and forecast 2010-2033 - excluding diabetes
12.2.Diabetes management skin patch market forecasts
12.2.1.Forecast: introduction
12.2.2.Forecast method: Company revenue in diabetes management
12.2.3.Skin patches for diabetes management: market forecast 2022-2033
12.2.4.CGM: annual revenue forecast 2022-2033
12.2.5.CGM: methodology and assumptions
12.2.6.CGM: forecasted uptake by type 2 and prediabetes
12.2.7.CGM: Milestones
12.2.8.CGMs by population adoption proportion
12.2.9.Patch pumps revenue forecast 2023-2033
12.3.Cardiac rhythm monitoring skin patch market forecasts
12.3.1.Cardiac rhythm management forecasting methodology
12.3.2.Cardiac rhythm management global historic market data 2010-2021
12.3.3.Cardiac rhythm management global market forecast 2021-2033
12.3.4.Cardiac rhythm management global market forecast 2010-2033
12.3.5.Cardiac rhythm management global market forecast 2010-2033
12.4.General patient monitoring skin patch market forecasts
12.4.1.Methodology for forecasting general patient monitoring
12.4.2.General patient monitoring skin patches global market forecast 2023-2033
12.4.3.General patient monitoring skin patches global market historic data and forecast 2010-2033
12.5.Temperature sensing skin patch market forecasts
12.5.1.Temperature sensing skin patches global market forecast 2023-2033
12.6.Electrical stimulation skin patch market forecasts
12.6.1.Electrical stimulation skin patches: market data (2010-2020)
12.6.2.Electrical stimulation skin patches: market forecast (2021-2033)
12.6.3.Electrical stimulation skin patches: market data and forecast (2010-2033)
12.7.Iontophoresis skin patch market forecasts
12.7.1.Iontophoresis skin patches: market forecast (2021-2033)
12.7.2.Iontophoresis skin patches: market data and forecast (2010-2033)
13.COMPANY PROFILES
13.1.Abbott Diabetes care
13.2.Agamatrix
13.3.Biobeat
13.4.BiointelliSense
13.5.Bioness
13.6.Bittium
13.7.Blue Spark
13.8.Boston Scientific (Preventice solutions)
13.9.Byteflies
13.10.Cardiomo
13.11.Cortrium
13.12.Dexcom
13.13.Diabeloop
13.14.Epicore
13.15.FirstKind
13.16.GlucoRx
13.17.Grapheal
13.18.HiDow
13.19.Hivox Biotek
13.20.Infinovo
13.21.iRhythm
13.22.Isansys
13.23.Leaf Healthcare
13.24.LifeScience Technology
13.25.LifeSignals
13.26.Medtronic
13.27.Medtrum
13.28.Mezoo
13.29.Philips
13.30.Phillips Biotelemetry
13.31.Preventice Solutions
13.32.QT Medical
13.33.Raiing
13.34.Roche
13.35.Rooti
13.36.Scottcare
13.37.Seers technology
13.38.Sigknow
13.39.Singular Wings Medical
13.40.SPR Therapeutics
13.41.SteadySense
13.42.The surgical company
13.43.Tidepool
13.44.Triple W
13.45.VitalConnect
13.46.Vivalink
 

価格および注文方法

電子皮膚パッチ 2023-2033年

£$¥
電子版_PDF(ユーザー 1-5名)
£5,495.00
電子版_PDF(ユーザー 6-10名)
£7,745.00
電子版_PDFおよびハードコピー1部(ユーザー 1-5名)
£6,095.00
電子版_PDFおよびハードコピー1部(ユーザー 6-10名)
£8,345.00
電子版_PDF(ユーザー 1-5名)
$6,500.00
電子版_PDF(ユーザー 6-10名)
$9,200.00
電子版_PDFおよびハードコピー1部(ユーザー 1-5名)
$7,250.00
電子版_PDFおよびハードコピー1部(ユーザー 6-10名)
$9,950.00
電子版_PDF(ユーザー 1-5名)
€6,250.00
電子版_PDF(ユーザー 6-10名)
€8,600.00
電子版_PDFおよびハードコピー1部(ユーザー 1-5名)
€6,950.00
電子版_PDFおよびハードコピー1部(ユーザー 6-10名)
€9,300.00
電子版_PDF(ユーザー 1-5名)
¥826,000
電子版_PDF(ユーザー 6-10名)
¥1,126,000
電子版_PDFおよびハードコピー1部(ユーザー 1-5名)
¥924,000
電子版_PDFおよびハードコピー1部(ユーザー 6-10名)
¥1,224,000
Click here to enquire about additional licenses.
If you are a reseller/distributor please contact us before ordering.
お問合せ、見積および請求書が必要な方はm.murakoshi@idtechex.com までご連絡ください。

レポート概要

スライド 233
フォーキャスト 2033
発行日 Oct 2022
ISBN 9781915514295
 

コンテンツのプレビュー

pdf Document Sample pages
pdf Document Webinar Slides
 
 
 
 

Subscription Enquiry